Effectiveness of Intravenous Tranexamic Acid in Reducing Blood Loss During and After Cesarean Section

• Status: Unknown status
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the efficacy and safety of tranexamic acid in the reducing the blood loss during and after elective LSCS will be investigated.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams Maternity Hospital
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• - Women undergoing caesarean delivery for various elective indications.

• Full term primiparas / multiparas.

• Singleton pregnancy being delivered by LSCS.

Exclusion Criteria:

• - Medical problems involving the heart, liver, kidney and brain .

• Blood disorders.

• Allergy to tranexamic acid.

• History of thromboembolic disorders, abnormal placentation, severe pre-eclampsia, uterine anomalies and pathology.

• Multiple pregnancy, macrosomia.

• Polyhydromnios .

• Patients requiring blood transfusion due to anemia